GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 receptor binding domain in complex with antibodies CC12.3 and CR3022

Analyse Crystal structure of SARS-cov-2 receptor binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XC7
Type
protein
Length
1,065 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; CR3022 heavy chain; CR3022 light chain; CC12.3 heavy chain; CC12.3…
UniProt
P0DTC2
Ligands
NAG, BMA
Pockets
14 · best druggability 0.66

Structure

x-ray diffraction · 5 distinct chains · 7% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike protein S1protein19317% helix, 29% strandP0DTC2
HCR3022 heavy chainprotein2187% helix, 50% strand—
LCR3022 light chainprotein2215% helix, 51% strand—
CCC12.3 heavy chainprotein2205% helix, 51% strand—
DCC12.3 light chainprotein2134% helix, 51% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • BMA · beta-D-mannopyranose · sugar

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12070.660.8526empty
24510.590.7559empty
33310.570.7648empty
43060.530.7545empty
51130.490.8023empty

Interfaces

6 interfaces between chains.

  • H–L · 1896 Ų buried · 11 hydrogen bonds · protein-protein
  • C–D · 1729 Ų buried · 18 hydrogen bonds · protein-protein
  • A–C · 749 Ų buried · 15 hydrogen bonds · protein-protein
  • A–H · 622 Ų buried · 8 hydrogen bonds · protein-protein
  • A–L · 413 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 13 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 6XC7 · Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.